Alocril is a drug owned by Allergan Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 22, 2012. Details of Alocril's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| USRE38628 | Pharmaceutical compositions |
Aug, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Alocril is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Alocril's family patents as well as insights into ongoing legal events on those patents.
Alocril's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Alocril's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 22, 2012 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Alocril Generic API suppliers:
Nedocromil Sodium is the generic name for the brand Alocril. 1 company has already filed for the generic of Alocril. Check out the entire list of companies who have already received approval for Alocril's generic
About Alocril
Alocril is a drug owned by Allergan Inc. It is used for managing conditions involving antibody-antigen reactions. Alocril uses Nedocromil Sodium as an active ingredient. Alocril was launched by Allergan in 1999.
Approval Date:
Alocril was approved by FDA for market use on 08 December, 1999.
Active Ingredient:
Alocril uses Nedocromil Sodium as the active ingredient. Check out other Drugs and Companies using Nedocromil Sodium ingredient
Treatment:
Alocril is used for managing conditions involving antibody-antigen reactions.
Dosage:
Alocril is available in solution/drops form for ophthalmic use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION/DROPS | Discontinued | OPHTHALMIC |